Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma.
Abstract
We report a woman who developed BIA-ALCL 9 years after saline implant placement. The lymphoma manifested as a mass lesion associated with axillary lymphadenopathy. She was successfully treated with brentuximab vedotin with minimal toxicity. Brentuximab vedotin may be a promising frontline therapeutic modality for patients with BIA-ALCL.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 합병증 | bia-alcl
|
보형물연관 역형성대세포림프종 | dict | 2 | |
| 해부 | brentuximab vedotin
|
scispacy | 1 | ||
| 해부 | breast
|
유방 | dict | 1 | |
| 재료 | saline implant
|
생리식염수 보형물 | dict | 1 | |
| 약물 | brentuximab vedotin
|
C2973446
brentuximab vedotin
|
scispacy | 1 | |
| 약물 | saline
|
scispacy | 1 | ||
| 질환 | breast implant-associated anaplastic large-cell lymphoma
|
C4528210
Breast implant-associated anaplastic large-cell lymphoma
|
scispacy | 1 | |
| 질환 | lymphoma
|
C0024299
Lymphoma
|
scispacy | 1 | |
| 질환 | toxicity
|
C0040539
Toxicity aspects
|
scispacy | 1 | |
| 질환 | BIA-ALCL 9
|
scispacy | 1 | ||
| 기타 | axillary lymphadenopathy
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- The Plastic Surgery In-Service Examination: A Scoping Review.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.